MYICX Performance — NYLI WMC International Research Equity Fund, Class C
Data updated: 2026-09-23
MYICX returned +12.40% year to date and +30.99% over one year to Jul 2026. Annualised returns are +17.28% over 3 years and +8.75% over 5 years. The fund beat its International Mid-Cap Blend category average: $100 invested three years ago grew to $161, against $152 for the category, and to $131 over one year, against $120. Volatility over the past three years was 13.12% a year. In the 12 months to Jul 2026 the fund lost a net $13.8M, and assets reached $254.27M.
MYICX Growth of $100
What $100 invested in NYLI WMC International Research Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Mid-Cap Blend category average over the same months.
| Period | MYICX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $131 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $161 | $152 |
| 5 years (Aug 2021 – Jul 2026) | $152 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $178 | $191 |
MYICX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +12.40% |
| 1 year | +30.99% |
| 3 years (annualised) | +17.28% |
| 5 years (annualised) | +8.75% |
MYICX Annual Returns
Calendar-year total returns of NYLI WMC International Research Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +12.40% |
| 2025 | +37.15% |
| 2024 | +6.13% |
| 2023 | +11.94% |
| 2022 | −17.14% |
| 2021 | +9.25% |
| 2020 | +0.42% |
| 2019 (Aug–Dec) | +6.70% |
MYICX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.5% | +4.4% | −9.1% | +7.1% | +3.8% | −0.3% | +0.3% | — | — | — | — | — |
| 2025 | +3.9% | +2.6% | −0.4% | +2.9% | +5.4% | +3.5% | −1.1% | +4.6% | +4.5% | +2.7% | +0.6% | +3.1% |
| 2024 | −2.1% | +3.0% | +3.6% | −0.8% | +4.2% | −2.6% | +2.9% | +3.3% | +1.5% | −4.2% | −0.1% | −2.3% |
| 2023 | +8.0% | −3.2% | +1.8% | +1.8% | −2.6% | +4.3% | +3.1% | −5.1% | −4.1% | −3.7% | +7.6% | +4.5% |
| 2022 | −3.6% | −3.2% | −0.7% | −8.0% | +1.5% | −9.8% | +4.0% | −4.0% | −9.4% | +5.2% | +13.9% | −2.0% |
| 2021 | −0.1% | +3.0% | +1.0% | +4.1% | +2.5% | −0.8% | −0.8% | +1.2% | −2.9% | +3.3% | −4.7% | +3.7% |
| 2020 | −1.8% | −8.6% | −16.5% | +5.4% | +3.9% | +4.1% | +2.1% | +5.0% | −2.3% | −3.6% | +11.4% | +4.5% |
| 2019 | — | — | — | — | — | — | — | −2.9% | +2.5% | +2.9% | +0.3% | +3.9% |
MYICX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 13.12%
- 3-year Sharpe ratio: 0.97 (vs 4.5% risk-free rate)
- Best month: +7.59% (Nov 2023)
- Worst month: −9.12% (Mar 2026)
MYICX Fund Flows
Monthly money in and out of NYLI WMC International Research Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$13.8M
- 12-month gross sales (incl. reinvestments): $62.6M
- Sales ÷ redemptions: 0.82×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $2.1M | $17.5M | −$15.3M |
| Jun 2026 | $2.1M | $13.5M | −$11.5M |
| May 2026 | $2.1M | $11.7M | −$9.7M |
| Apr 2026 | $10.1M | $1.1M | $9.0M |
| Mar 2026 | $3.8M | $2.2M | $1.6M |
| Feb 2026 | $6.5M | $1.3M | $5.2M |
| Jan 2026 | $13.6M | $2.2M | $11.4M |
| Dec 2025 | $9.3M | $3.9M | $5.5M |
| Nov 2025 | $1.2M | $10.2M | −$9.0M |
| Oct 2025 | $9.2M | $9.7M | −$490K |
| Sep 2025 | $840K | $1.2M | −$323K |
| Aug 2025 | $1.8M | $1.9M | −$105K |
MYICX Assets Under Management
Net assets of NYLI WMC International Research Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $254.27M |
| 2026-04-30 | $279.49M |
| 2026-01-31 | $258.44M |
| 2025-10-31 | $232.71M |
| 2025-07-31 | $207.24M |
| 2025-04-30 | $204.99M |
| 2025-01-31 | $215.56M |
| 2024-10-31 | $203.98M |
| 2024-07-31 | $175.23M |
| 2024-04-30 | $175.32M |
| 2024-01-31 | $157.40M |
| 2023-10-31 | $146.40M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.